• Source: AC-262,536

AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM). Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5 nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the levator ani muscle weight increase of testosterone, but only around 27% of its maximal effect on prostate gland weight. It is an aniline SARM related to ACP-105 and vosilasarm (RAD140).




References

Kata Kunci Pencarian:

• AC-262,536
• YK-11
• Drostanolone propionate
• Chlorodehydromethyltestosterone
• Testosterone isocaproate
• Trenbolone
• Azelaic acid
• Methasterone
• Drostanolone
• Oxymetholone